Australia’s cannabis industry has huge global potential, but we must innovate to maximise it by Martin Lane January 12, 2021April 29, 2024 Cymra Life Sciences chief operating officer Simon Pettinger argues cannabis companies need to think differently to […]
Analysis: what the Government’s proposed reforms mean for Australia’s medicinal cannabis industry by Rhys Cohen December 23, 2020April 26, 2024
A victory for common sense, but there’s still a difficult road ahead by Rhys Cohen December 17, 2020April 26, 2024
The way pharmaceutical reps sell to doctors is highly effective – if you don’t mind a hefty side of bias by Martin Lane December 15, 2020April 26, 2024
Calls grow for uniform lab testing as third party analysis exonerates products ‘failed’ by the TGA by Steve Jones December 10, 2020April 26, 2024
Reasons to be cheerful: cannabis has the momentum as we head into 2021 by Martin Lane December 8, 2020April 26, 2024
Podcast: Should the industry be helping the TGA do its job? by Josie Tutty December 3, 2020May 2, 2024
Only industry-wide transparency will ensure cannabis advertising rules are fair and consistent by Rhys Cohen December 3, 2020April 26, 2024
Is Pete Evans the man we want to represent medicinal cannabis? by Martin Lane December 2, 2020April 26, 2024
Advertising complaints and the TGA: Too many cowboys (not enough sheriffs) by Rhys Cohen November 26, 2020April 26, 2024